Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.05 - Poster Session 1 - Preclinical Models of Therapeutics/Imaging

    • Type: Poster Session
    • Track: Biology
    • Presentations: 25
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.05-015 - Assessment of the activity of Pemetrexed and Dasatinib as single agents and in combination in three malignant pleural mesothelioma cell lines

      09:30 - 09:30  |  Author(s): V. Monica

      • Abstract

      Loading...

  • +

    P1.10 - Poster Session 1 - Chemotherapy

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 57
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.10-056 - The Elderly Patient Individualized Chemotherapy Trial (EPIC): A Randomized Phase III Multicenter Trial of Customized Chemotherapy versus Standard of Care for 1st Line Treatment of Elderly Patients with Advanced Non-Small-Cell Lung Cancer

      09:30 - 09:30  |  Author(s): T. Vavala'

      • Abstract

      Loading...

  • +

    P1.11 - Poster Session 1 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 45
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.11-033 - Afatinib in EGFR mutant non-small-cell lung cancer patients with acquired resistance to reversible EGFR-TKIs

      09:30 - 09:30  |  Author(s): F. Cappuzzo

      • Abstract

      Loading...

  • +

    P1.23 - Poster Session 1 - Tobacco Control, Prevention and Chemoprevention

    • Type: Poster Session
    • Track: Prevention & Epidemiology
    • Presentations: 3
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.23-001 - The real role of health care professionals in providing smoking cessation counselling among lung cancer patients: preliminary data

      09:30 - 09:30  |  Author(s): S. Vallone

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.07 - Randomized Proteomic Stratified Phase III Study of Second Line Erlotinib (E) versus Chemotherapy (CT) in Patients with Inoperable Non-Small Cell Lung Cancer (PROSE): Secondary Endpoint Analysis

      11:35 - 11:45  |  Author(s): V. Gregorc

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    E03 - Chemotherapy for NSCLC

    • Type: Educational Session
    • Track: Medical Oncology
    • Presentations: 5
    • Moderators:R. Pirker
    • Coordinates: 10/28/2013, 14:00 - 15:30, Bayside Auditorium A, Level 1
  • +

    P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 50
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.06-013 - Genetic profiling of lung cancer in young adults patients: early data assessment using Next-Generation Sequencing.

      09:30 - 09:30  |  Author(s): T. Vavala'

      • Abstract

      Loading...

  • +

    P2.11 - Poster Session 2 - NSCLC Novel Therapies

    • Type: Poster Session
    • Track: Medical Oncology
    • Presentations: 46
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.11-023 - BE-Positive: Gefitinib in first-line treatment of advanced non-small cell lung cancer (NSCLC) patients harboring activating epidermal growth factor receptor (EGFR) mutations. A combined retrospective and prospective analysis from Italian patients.

      09:30 - 09:30  |  Author(s): S. Novello

      • Abstract

      Loading...

  • +

    P2.18 - Poster Session 2 - Pathology

    • Type: Poster Session
    • Track: Pathology
    • Presentations: 23
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.18-014 - Impact of Non Small Cell Lung Cancer (NSCLC) immunophenotyping in chemotherapy response.

      09:30 - 09:30  |  Author(s): L. Righi

      • Abstract

      Loading...

  • +

    P2.24 - Poster Session 2 - Supportive Care

    • Type: Poster Session
    • Track: Supportive Care
    • Presentations: 61
    • Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P2.24-015 - The role of WALCE (Women Against Lung Cancer in Europe) in helping patients and their caregivers to cope with cancer.

      09:30 - 09:30  |  Author(s): S. Vallone

      • Abstract

      Loading...